Viral vector vaccines use a version of a mild virus to safely deliver instructions in the form of genetic code to our body cells. These instructions enable your body to produce a harmless piece of the ...

In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the ...

Cornell University researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu ...

The other COVID-19 vaccines authorised for use in the EU are mRNA vaccines (Pfizer/BioNTech and Moderna) or viral vector vaccines (AstraZeneca and Janssen).

The viral vector and plasmid DNA manufacturing market is expanding significantly due to ongoing innovation in recent years. Advanced gene therapy and vaccine development have seen a sudden surge ...